The Opening of BioLabs Tokyo: The Potential for Investment in Japan's Life Sciences Sector and Ecosystem Development (Part 1)

Nov 19, 2026

Susan Chase, Susan Chase, Chief Business Officer, BioLabs HQ.

U.S.-based BioLabs Opens First Asian Location in Tokyo: The Potential They See in the Japanese Market

In 2026, U.S.-based BioLabs, which operates incubation facilities for life science startups, opened "BioLabs Tokyo" in Shinkiba, Tokyo, as its first location in Asia. Why did this company, which has supported the development of life science ecosystems around the world, choose the Japanese market? Through an interview with BioLabs' headquarters, we learned about the background of their expansion into Japan and their expectations for the Japanese market.

BioLabs: Born from an Entrepreneur's Own Experience

BioLabs was founded in 2009. Founder Johannes Fruehauf experienced entrepreneurship while working as a postdoctoral researcher in the United States but found it challenging that securing research space and installing equipment required significant costs and time. In addition to these experiences, a request from a fellow researcher to share laboratory space led to the concept of a shared lab specializing in the life science field.

Today, BioLabs operates more than 22 locations primarily in North America and Europe, providing startups not only with research space and laboratory equipment, but also with support essential for growth, including funding, talent acquisition, and corporate partnerships.

The company places importance on "creating an environment where entrepreneurs can focus on research and development" and has built a system that enables resident companies to accelerate their R&D activities. One of its distinguishing features is its network of more than 70 sponsor companies, including pharmaceutical companies, equipment manufacturers, and service providers.

Susan in the lab

Cell and Tissue Culture Laboratory

Focusing on Japan with World-Class Research Capabilities

The primary reason BioLabs became interested in Japan was its high regard for Japan's research capabilities.

The company noted that in addition to Japanese universities and research institutions possessing world-class research capabilities, it was also drawn to the concentration of major pharmaceutical companies and the presence of highly skilled talent. Susan Chase, Chief Business Officer, stated," The depth of Japan's basic research is highly attractive, and there are many technologies and research outcomes that can compete in the global market."

Additionally, since 2019, the company has been involved in educational programs and accelerator programs in Japan, collaborating with organizations such as iCONM (Innovation Center of NanoMedicine) in Kawasaki City and Astellas at SakuLab . Through these activities, they deepened their understanding of Japan's startup ecosystem and strengthened their conviction to open their own location.

Choosing Tokyo as the First Location in Asia

Discussion space adjacent to the laboratory at BioLabs Tokyo

The opening of BioLabs Tokyo was significantly supported by partnerships with Mitsui Fudosan and LINK-J.

Susan stated,"The right timing, the right location, and the right partners all came together." Furthermore, pharmaceutical company AbbVie has joined as a founding sponsor, and Shimadzu Corporation, Merck, Proteros,and DeNovix have also joined as sponsor companies, indicating high expectations from the industry.

According to the company, interest in the Japanese market is growing through its network of locations around the world. BioLabs also emphasizes creating an environment where Japanese startups can connect with overseas researchers, investors, and pharmaceutical companies by leveraging its network of 21 locations worldwide. In addition to Japanese companies expanding overseas, there is an increasing number of cases where overseas startups and researchers are seeking connections with the Japanese market. The Tokyo location is also expected to serve as a hub for such international exchange.

Japan's Challenges: "Commercialization" and "Fundraising"

On the other hand, the company cites the commercialization of research outcomes and fundraising as challenges in Japan's life sciences sector.

Susan also noted that Japan's research and technical capabilities themselves are at the global level, and the reliability regarding regulations and quality is also high. Furthermore, she stated, "Systems to connect research outcomes to commercialization and further expansion of venture investment will become important going forward."

BioLabs aims to help address these challenges through creating connections with sponsor companies and providing support programs for startups. They will support the commercialization of research outcomes and overseas expansion through their network of locations around the world and partnerships with more than 70 sponsor companies, including pharmaceutical companies and equipment manufacturers.

"Come and try. Don't be afraid of failure."

When asked for a message to researchers and entrepreneurs in Japan, Susan emphasized, "Don't be afraid. Come and try, and don't be afraid of failure."

"Your science is entirely capable of changing the world. You don't have to do this alone, you don't have to build it from scratch. There are tools and a number of programs that create opportunities for companies. So please do try," Susan said.

BioLabs positions the Tokyo location as the first step in its expansion into Japan. Going forward, they plan to support the creation of innovation from Japan by connecting domestic and international companies, research institutions, and investors.

In Part 2, we will visit "BioLabs Tokyo," the first location in Asia, and introduce the environment provided for Japanese life science startups and the ripple effects on the Japanese market.

Make the Most of JETRO

We can provide you with the latest regional information from our offices throughout Japan, as well as various support services related to investment in Japan.

Also, as a first step in exploring the potential of this growth market, please take a look at JETRO's "Key Industries for Investment in Japan: Life Sciences" report.

JETRO supports your business in Japan

We provide consistent one-stop service for establishing a base or expanding business in Japan. See the details of support services that JETRO provides when setting up business in Japan.

Contact Us

Investing in and collaborating with Japan

We will do our very best to support your business expansion into and within Japan as well as business collaboration with Japanese companies. Please feel free to contact us via the form below for any inquiries.

Inquiry Form

JETRO Worldwide

Our network covers over 50 countries worldwide. You can contact us at one of our local offices near you for consultation.

Worldwide Offices